OK, I too am suffering from Diabetes Blog Week withdrawal. I find myself still trolling Twitter trying to discover more great posts that I missed. In particular, it seems last Saturday’s planned “wild card” topic — brag about your triumph or commiserate about your D-blooper — got changed at the last minute to a collection of diabetes snapshots. Which I loved. Too bad for me though, because I had a really good blooper to share.…Read more »
Sunday, May 16, was the final day of this year’ s Diabetes Blog Week — which I hope will be an annual affair. The closing topic was life after a cure. I must admit that weekends are reserved for my family, so I didn’t participate in real-time, but the topic is fascinating!
Of course I could go on myself about how I’d don my hiking boots and run outside to trample all my diabetes supplies,…
Jessica Bernstein wants to take “control” out of the diabetes vocabulary. So read the headline when she was featured in the San Francisco Chronicle last week. Jessica is a San Francisco Bay Area psychologist who was diagnosed herself with type 1 diabetes when she was just a year old. She’s spent much of her adult life working with people with chronic illnesses, and fundamentally believes that our culture has got the approach to “suffering” all…Read more »
If you enjoy “The Biggest Loser” or other reality shows in that vein, and you have diabetes, you’re gonna love this!!
Several years in the making, the TCOYD “Extreme Diabetes Makeover” program is underway now; episodes will start airing in May on TCOYD.org and its own TV channel, on YouTube, and at RealAge.com, the popular consumer health website run by Dr. Mehmet Oz of Oprah fame and his colleague Dr. Michael Roizen.
Wonder what I’m…
Novo Nordisk is well-known in the diabetes community for its insulins, Novolog and Levemir, used to treat mainly type 1 diabetes. But in the last year, Novo launched a new kind of injectable, a “first line of defense for people with type 2 diabetes” called Victoza (generic: liraglutide). It’s a glucagon-like peptide-1 (GLP-1) drug designed to stimulate insulin secretion when hyperglycemia (high blood sugar) is present.
Victoza is still the new kid on the block…Read more »